Keywords: achieving, synergy, through, diversity, focus, ximed, group
Achieving synergy through diversity; focus on XiMed Group of the UK
Article | 24 May 2000
At a time when many small biotechnology and pharmaceutical developmentcompanies are adopting a virtual approach to operations, outsourcing as many ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
